Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia, Myeloid, Chronic-Phase 5Blast Crisis 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thymus Neoplasms 1Thymoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 3ibrutinib 2Rituximab 2Imatinib Mesylate 2ziconotide 1ruxolitinib 1ponatinib 1ofatumumab 1nilotinib 1lonafarnib 1fludarabine 1bosutinib 1Surveys and Questionnaires 1Specimen Handling 1SLC25A33 protein, human 1Povidone-Iodine 1Physical Therapy Modalities 1Pentostatin 1Lenalidomide 1Dasatinib 1Cyclophosphamide 1Bone Marrow Transplantation 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Bronchiolitis Obliterans Syndrome × bosutinib × Clear all
NCT02638467 2020-11-05

Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy

University of Milano Bicocca

Phase 2 Completed
2 enrolled
Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡